BIOBANK LPCE-NICE CHEST



Similar documents
BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST

Pathology of lung cancer

Update on Mesothelioma

Neoplasms of the LUNG and PLEURA

YOUR LUNG CANCER PATHOLOGY REPORT

This factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Rare Thoracic Tumours

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

The Diagnosis of Cancer in the Pathology Laboratory

Primary -Benign - Malignant Secondary

P R E F E I T U R A M U N I C I P A L D E J A R D I M

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

General Information About Non-Small Cell Lung Cancer

INFLAMMATORY PLEURAL EFFUSION

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Lung Cancer: Diagnosis, Staging and Treatment

Diagnosis of Mesothelioma Pitfalls and Practical Information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

Male. Female. Death rates from lung cancer in USA

Survival analysis of 220 patients with completely resected stage II non small cell lung cancer

1.- L a m e j o r o p c ió n e s c l o na r e l d i s co ( s e e x p li c a r á d es p u é s ).

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Diagnostic Challenge. Department of Pathology,

The develpemental origin of mesothelium

Recommendations for the Reporting of Pleural Mesothelioma

POLICY A. INDICATIONS

The National Clinical Lung Cancer Audit (LUCADA)

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

PRIMARY LUNG CANCER TREATMENT

Summary of treatment benefits

Uses and Abuses of Pathology in Asbestos-exposed Populations

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Frozen Section Diagnosis

Early Prostate Cancer: Questions and Answers. Key Points

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,

Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

Understanding Pleural Mesothelioma

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

How To Write Lung Cancer Data Standards For Nhs Scotland

U.S. Department of Housing and Urban Development: Weekly Progress Report on Recovery Act Spending

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

About lung cancer. Contents. The lungs

Case based applications part III

Cardiac Masses and Tumors

Stage I, II Non Small Cell Lung Cancer

III II II III. ge: /ears sex: Male Access

بسم هللا الرحمن الرحيم

What is Mesothelioma?

How To Treat Lung Cancer At Cleveland Clinic

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

1. Oblast rozvoj spolků a SU UK 1.1. Zvyšování kvalifikace Školení Zapojení do projektů Poradenství 1.2. Financování

Endometrial Cancer Treatment

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

CHAPTER 3: LUNG CANCER OVERVIEW

Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Non-Small Cell Lung Cancer

Lung Cancer Understanding your diagnosis

Put the human back in Human Resources.

E S T A D O D O C E A R Á P R E F E I T U R A M U N I C I P A L D E C R U Z C Â M A R A M U N I C I P A L D E C R U Z

<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012

How To Know When To Stage Lung Cancer

Table 12: Availability Of Workers Compensation Insurance Through Homeowner s Insurance By Jurisdiction

Targeted Therapy What the Surgeon Needs to Know

Chapter 14 Cancer of the Cervix Uteri

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Ovarian tumors Ancillary methods

Académie internationale de Pathologie - Division arabe XX ème congrès novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

SMALL CELL LUNG CANCER

Therapy of pleural effusions Modern techniques

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

SCD Case Study. Most malignant lesions of the tonsil are either lymphosarcoma or carcinoma.

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

TNM Staging of Head and Neck Cancer and Neck Dissection Classification

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

THYROID CANCER. I. Introduction

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Sternotomy and removal of the tumor

Lung Cancer. Understanding your diagnosis

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

DELRAY MEDICAL CENTER. Cancer Program Annual Report

Transcription:

HEST athologist :. BUTORI 08/01/2012 Time for frozen procedure : 45 mn LE / HU Unit atient : N LH 12-2304 N LB 12-0337 onsent : YES Age : 62 ID : MA H Diagnosis and staging : lung adenocarcinoma lymph node metastasis ptx N2 Diagnosis of frozen specimens : adenocarcinoma 1- al tissue specimens Size : 0.3 to 0.8 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 77 mg ercent of tumor cells : 5 % 4- ontrols of quality Not available erilesion

HEST athologist :. BUTORI 08/07/2012 Time for frozen procedure : 32 mn LE / HU Unit atient : N LH 12-2338 N LB 12-0339 onsent : YES Age : 73 ID : A JE Diagnosis and staging : acinar invasive adenocarcinoma pt2bno Diagnosis of frozen specimens : acinar invasive adenocarcinoma 1- al tissue specimens Size : 6 cm Location : right upper lobe Weights : D1 : 42 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 58 mg, R2 : 115 mg, R3 : 43 mg, R4 : 62 mg ercent of tumor cells : 40 % 2- erilesional tissue specimens Location : peri tumoral Histology : alveolitis 2D- Specimens for diagnosis : Weights : D1 : 80 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 46 mg, R2 : 78 mg, R3 : 45 mg, R4 : 90 mg 4- ontrols of quality For diagnosis bank : YES 7X500µL erilesion

HEST athologist :. BUTORI 08/07/2012 Time for frozen procedure : 40 mn LE / HU Unit atient : N LH 12-2333 N LB 12-0340 onsent : YES Age : 75 ID : JA RO Diagnosis and staging : non small cell carcinoma lymph node metastasis Diagnosis of frozen specimens : non small cell carcinoma 1- al tissue specimens Size : 0.3 to 0.6 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 88 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 32 mg, R2 : 62 mg, R3 : 24 mg ercent of tumor cells : 1 % 4- ontrols of quality Not available erilesion

HEST LE / HU Unit athologist : V. HOFMAN 08/08/2012 lamp : 10 mn ; Frozen procedure : 53 mn ; T : 63 mn atient : N LH 12-2347 N LB 12-0342 onsent : YES Age : 55 Sex : F ID : MA L Diagnosis and staging : post chemotherapy acinar adenocarcinoma grade 3 ypt2bn1 Diagnosis of frozen specimens : acinar adenocarcinoma grade 3 Rare tumor cells 1- al tissue specimens Size : 6 x 5 cm Location : right lower lobe Weights : D1 : 173 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 295 mg, R2 : 130 mg, R3 : 179 mg, R4 : 114 mg ercent of tumor cells : 2 % 2- erilesional tissue specimens Location : right lower lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 106 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 116 mg, R2 : 131 mg, R3 : 92 mg, R4 : 103 mg 4- ontrols of quality For diagnosis bank : YES 7x500µl erilesion

HEST athologist :. BUTORI 08/09/2012 Time for frozen procedure : 13 mn LE / HU Unit atient : N LH 12-2370 N LB 12-0344 onsent : YES Age : 74 ID : NI RA Diagnosis and staging : lung adenocarcinoma pleural metastasis Diagnosis of frozen specimens : adenocarcinoma acinar variant grade 3 1- al tissue specimens Size : biopsies 1 to 4 cm Location : right parietal pleura 2- erilesional tissue specimens None Weights : D1 : 62 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 54 mg, R2 : 90 mg, R3 : 60 mg, R4 : 70 mg ercent of tumor cells : 20 % 4- ontrols of quality For diagnosis bank : YES (Tube R1) : - : 0.066 µg/µl ; Tot qty : 13.1 µg - DO 260/280 : 1.99 ; R yro EGFr OK Not available BioBank erilesion

HEST athologist : V. HOFMAN 08/09/2012 Time for frozen procedure : 11 mn LE / HU Unit atient : N LH 12-2374 N LB 12-0345 onsent : YES Age : 75 ID : JU AR Diagnosis and staging : organising pneumonia with fibrinous pattern (amiodarone) advice Lyon Diagnosis of frozen specimens : organising pneumonia with fibrinous pattern 1- al tissue specimens Size : 4 cm Location : left lower lobe 2- erilesional tissue specimens None Weights : D1 : 58 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 72 mg, R2 : 105 mg, R3 : 87 mg, R4 : 62 mg 4- ontrols of quality Not available erilesion

HEST athologist :. BUTORI 08/13/2012 Time for frozen procedure : 40 mn LE / HU Unit atient : N LH 12-2382 N LB 12-0347 onsent : YES Age : 74 ID : RO EM Diagnosis and staging : sarcomatoid mesothelioma Diagnosis of frozen specimens : sarcomatoid mesothelioma 1- al tissue specimens Size : 0.5 to 4 cm Location : left parietal pleura 2- erilesional tissue specimens None Weights : D1 : 31 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 38 mg, R2 : 33 mg, R3 : 28 mg ercent of tumor cells : 70 % 4- ontrols of quality Not available 7x500µl erilesion

HEST athologist :. BUTORI 08/14/2012 Time for frozen procedure : 24 mn LE / HU Unit atient : N LH 12-2389 N LB 12-0348 onsent : YES Age : 59 ID : GR MU Diagnosis and staging : sarcomatoid carcinoma bilateral mediastinal lymph node metastasis Diagnosis of frozen specimens : sarcomatoid carcinoma 1- al tissue specimens Size : 0.3 to 1 cm Location : mediastinal 2- erilesional tissue specimens None Weights : D1 : 28 mg 1R- Specimens for research : Nb : 3 Weights : R1 : 26 mg, R2 : 30 mg, R3 : 61 mg ercent of tumor cells : 90 % 4- ontrols of quality Not available erilesion

HEST athologist :. BUTORI 08/20/2012 Time for frozen procedure : 36 mn LE / HU Unit atient : N LH 12-2421 N LB 12-0351 onsent : YES Age : 78 ID : E RO Diagnosis and staging : invasive adenocarcinoma pt3n0 Diagnosis of frozen specimens : papillary adenocarcinoma 1- al tissue specimens Size : 7 cm Location : right upper lobe Weights : D1 : 216 mg 1R- Specimens for research : Nb : 12 Weights : R1 : 128 mg, R2 : 272 mg, R3 : 173 mg, R4 : 102 mg, R5 : 32 mg, R6 : 28 mg, R7 : 39 mg, R8 : 42 mg, R9 : 51 mg, R10 : 15 mg, R11 : 45 mg, R12 : 32 mg ercent of tumor cells : 60 % 2- erilesional tissue specimens Location : right upper lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 80 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 399 mg, R2 : 164 mg, R3 : 229 mg, R4 : 215 mg For diagnosis bank : YES 4- (Tube D1: échantillon coupé en deux) : L1 - : 0.30628 µg/µl ; Tot qty : 57.64µg - DO 260/280 : 2.02 ; R GADH abandonnée L2 - : 0.15998 µg/µl ; Tot qty : 28.67 µg - DO 260/280 : 2 ; R GADH abandonnée al Tube R5 - : 0.263 µg/µl ; Tot qty :47.1 µg - DO 260/280 : 1.97 ; R GADH OK Tube R6 - : 0.260 µg/µl ; Tot qty :46.5 µg - DO 260/280 : 1.98 ; R GADH OK Tube R7 - : 0.272 µg/µl ; Tot qty :48.8 µg - DO 260/280 : 1.96 ; R GADH OK Tube R8 - : 0.284 µg/µl ; Tot qty :51.2 µg -DO 260/280 : 1.96 ; R GADH OK Tube R9 - : 0.282 µg/µl ; Tot qty :50.9 µg - DO 260/280 : 1.96 ; R GADH OK Tube R10 - : 0.276 µg/µl ; Tot qty :49.6 µg -DO 260/280 : 1.97 ; R GADH OK Tube R11 - : 0.254 µg/µl ; Tot qty :45.4 µg -DO 260/280 : 1.96 ; R GADH OK Tube R12 - : 0.269 µg/µl ; Tot qty :48.3 µg - DO 260/280 : 1.97 ; R GADH OK BioBank LM 7X500µl erilesion

HEST athologist :. BUTORI 08/20/2012 Time for frozen procedure : 40 mn LE / HU Unit atient : N LH 12-2417 N LB 12-0352 ID : SM AK onsent : YES Age : 36 Diagnosis and staging : schwannoma of the right sympathic nerve Diagnosis of frozen specimens : schwannoma of the sympathic nerve 1- al tissue specimens Size : 0.9 cm Location : right sympathic nerve 2- erilesional tissue specimens None Weights : D1 : 227.5 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 161 mg, R2 : 168.8 mg, R3 : 160 mg, R4 : 134 mg ercent of tumor cells : 100 % 4- ontrols of quality For diagnosis bank : YES Not available erilesion

HEST athologist : V. HOFMAN 08/20/2012 Time for frozen procedure : 21 mn LE / HU Unit atient : N LH 12-2424 N LB 12-0353 onsent : YES Age : 77 Sex : F ID : OR IR Diagnosis and staging : typical carcinoid pt1an0 Diagnosis of frozen specimens : typical carcinoid 1- al tissue specimens Size : 1.5 x 1.2 cm Location : middle lobe Weights : D1 : 33 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 40 mg, R2 : 42 mg, R3 : 73 mg, R4 : 35 mg ercent of tumor cells : 90 % 2- erilesional tissue specimens Location : middle lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 46 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 53 mg, R2 : 45 mg, R3 : 42 mg, R4 : 25 mg 4- ontrols of quality 2x500µl erilesion

HEST LE / HU Unit athologist : M. ILIE 08/21/2012 lamp : 20 mn ; Frozen procedure : 20 mn ; T : 40 mn atient : N LH 12-2425 N LB 12-0354 onsent : YES Age : 53 ID : BO H Diagnosis and staging : clear cell adenocarcinoma pt2an0m0 Diagnosis of frozen specimens : clear cell adenocarcinoma 1- al tissue specimens Size : 3.5 x 3.2 x 3 cm Location : middle lobe Weights : D1 : 115 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 107 mg, R2 : 170 mg, R3 : 201 mg, R4 : 188 mg ercent of tumor cells : 40 % 2- erilesional tissue specimens Location : middle lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 89 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 60 mg, R2 : 108 mg, R3 : 93 mg, R4 : 100 mg 4- ontrols of quality For diagnosis bank : YES erilesion

HEST athologist :. BUTORI 08/21/2012 LE / HU Unit atient : N LH 12-2434 N LB 12-0355 onsent : YES Age : 56 ID : BO GI Diagnosis and staging : pseudo tumoral broncho pneumonia 7x500µl

HEST LE / HU Unit athologist : M. ILIE 08/22/2012 L1 : time for frozen procedure : 15 mn L2 + erilesional : clamp : 10 mn ; Frozen procedure : 50 mn ; T : 60 mn atient : N LH 12-2442 N LB 12-0356 onsent : YES Age : 81 ID : GH LU Diagnosis and staging : adenosquamous carcinoma pt2bn1m0 Diagnosis of frozen specimens : L1 : lymph node metastasis of adenosquamous carcinoma; L2 : adenosquamous carcinoma 1- al 1 tissue specimens Size : 3 x 2 cm Location : lymph node 11 Weights : D1 : 40 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 33 mg, R2 : 47 mg, R3 : 68 mg, R4 : 65 mg ercent of tumor cells : 20 % 2- erilesional tissue specimens Location : lower right lobe Histology : mild ephysema 2D- Specimens for diagnosis : Weights : D1 : 33 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 36 mg, R2 : 43 mg, R3 : 83 mg, R4 : 55 mg 3- al 2 tissue specimens Size : 6.7 x 6 x 5.8 cm Location : lower right lobe Weights : D1 : 108 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 115 mg, R2 : 94 mg, R3 : 82 mg, R4 : 104 mg ercent of tumor cells : 50 % 5- ontrols of quality 4- Morphological controls (mirrors) : 7x500µl 1 2 erilesion

HEST LE / HU Unit athologist : M. ILIE 08/23/2012 lamp : 10 mn ; Frozen procedure : 35 mn ; T : 45 mn atient : N LH 12-2453 N LB 12-0358 onsent : NO Age : 62 ID : RA MA Diagnosis and staging : squamous cell carcinoma (grade 2) focally keratinizing pt2bn1m1 Diagnosis of frozen specimens : squamous cell carcinoma 1- al tissue specimens Size : 4.7 x 4 x 3.5 cm Location : left upper lobe Weights : D1 : 100 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 74 mg, R2 : 56 mg, R3 : 47 mg, R4 : 55 mg ercent of tumor cells : 60 % 2- erilesional tissue specimens Location : left upper lobe Histology : mild emphysema 2D- Specimens for diagnosis : Weights : D1 : 53 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 55 mg, R2 : 50 mg, R3 : 63 mg, R4 : 37 mg 4- ontrols of quality Infection : YES (hepatitis) 7 x500µl erilesion

HEST LE / HU Unit athologist :. BUTORI 08/28/2012 lamp : 20 mn ; Frozen procedure : 61 mn ; T : 81 mn atient : N LH 12-2474 N LB 12-0359 onsent : NO Age : 73 ID : OU KO Diagnosis and staging : squamous cell carcinoma pt4n1 Diagnosis of frozen specimens : sqamous cell carcinoma 1- al tissue specimens Size : 9 x 6 cm Location : left lower lobe Weights : D1 : 345 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 196 mg, R2 : 208 mg, R3 : 234 mg, R4 : 174 mg ercent of tumor cells : 80 % 2- erilesional tissue specimens Location : basal pyramid Histology : fibrosis «honey comb» 2D- Specimens for diagnosis : Weights : D1 : 290 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 206 mg, R2 : 156 mg, R3 : 170 mg, R4 : 117 mg 4- ontrols of quality 7 x500µl erilesion

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0363 ID : RI RO onsent : YES NO Age : 23 Diagnosis and staging : healthy subjects Sex : F 6x500µl

HEST athologist : E. LONG-MIRA 08/29/2012 Time for frozen procedure : 15 mn LE / HU Unit atient : N LH 12-2495 N LB 12-0364 onsent : YES Age : 72 ID : SE BE Diagnosis and staging : acinous adenocarcinoma (pt1bn2mx) Diagnosis of frozen specimens : acinous adenocarcinoma 1- al tissue specimens Size : 2.5 x 2 x 2 cm Location : left upper lobe (ventral segment) Weights : D1 : 151 mg 1R- Specimens for research : Nb : 4 Weights : R1 : 97 mg, R2 : 130 mg, R3 : 81 mg, R4 : 103 mg ercent of tumor cells : 5 % 2- erilesional tissue specimens Location : left upper lobe Histology : normal 2D- Specimens for diagnosis : Weights : D1 : 140 mg 2R- Specimens for research : Nb : 4 Weights : R1 : 190 mg, R2 : 199 mg, R3 : 144 mg, R4 : 234 mg 4- ontrols of quality For diagnosis bank : YES erilesion

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0365 ID : MO E onsent : YES NO Age : 24 Diagnosis and staging : healthy subjects Sex : F 6 x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0366 ID : RO VI onsent : YES NO Age : 34 Diagnosis and staging : healthy subjects Sex : F 6x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0367 ID : FA NA onsent : YES NO Age : 37 Diagnosis and staging : healthy subjects Sex : F 5x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0368 ID : GH HA onsent : YES NO Age : 26 Diagnosis and staging : healthy subjects Sex : F 6 x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0369 ID : A LA onsent : YES NO Age : 27 Diagnosis and staging : healthy subjects Sex : F 6x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0370 ID : BE GU onsent : YES NO Age : 25 Diagnosis and staging : healthy subjects Sex : F 6x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0371 ID : I TH onsent : YES NO Age : 27 Diagnosis and staging : healthy subjects 6x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0372 ID : VA ST onsent : YES NO Age : 25 Diagnosis and staging : healthy subjects Sex : F 6x500µl

HEST athologist : M. ILIE 08/29/2012 LE / HU Unit atient : N LH / N LB 12-0373 ID : BU MA onsent : YES NO Age : 27 Diagnosis and staging : healthy subjects 6x500µl